Northwestern Medicine investigators have developed a new avenue to reprogram compromised immune cells to act against tumors, ...
A temporally resolved CRISPR-Cas9 screen reveals DAC-induced DNA damage drives trans-cell cycle cytotoxicity that depends on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback